Synthesis and in vitro antibacterial activities of 7-(4-alkoxyimino-3-hydroxypiperidin-1-yl)quinolone derivatives

Chinese Chemical Letters

Volumn 21, Issue 1, 2010, Pages 55-58

  Wang, Ju Xian ^a   Guo, Qiang ^a   Chai, Yun ^a   Feng, Lian Shun ^a   Guo, Hui Yuan ^a   Liu, Ming Liang ^a  

^a INSTITUTE OF MEDICINAL BIOTECHNOLOGY   (China)

Author keywords

Antibacterial activities; Fluoroquinolone; Synthesis

Indexed keywords

EID: 70749095206     PISSN: 10018417     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cclet.2009.07.011     Document Type: Article

References (12)

1. Hooper D.C., and Wolfson J.S. N. Engl. J. Med. 32 (1991) 384
2. Srivastava B.K., Solanki M., Mishra B., et al. Bioorg. Med. Chem. Lett. 17 (2007) 1924
3. Koga H., Itoh A., Murayama S., et al. J. Med. Chem. 23 (1980) 1358
4. Domagala J.M.J. Antimicrob. Chemother. 33 (1994) 685
5. Dang Z., Yang Y.S., Ji R.Y., et al. Bioorg. Med. Chem. Lett. 17 (2007) 4523
6. Wang X.Y., Guo Q., Wang Y.C., et al. Acta Pharm. Sin. 43 (2008) 819
7. Ishijima S.N., Kurokawa I., and Nakaya H.J. Infect. Chemother. 8 (2002) 187
8. Moriarty R.M., Hu H., and Gupta S.C. Tetrahedron Lett. 22 (1981) 1283
9. Takagi N., Fubasami H., and Matukubo H. EP 464823 (1992)
10. +).
11. w = 0.1413.
12. MICs were determined as described by the NCCLS (see National Committee for Clinical Laboratory Standards. 2001. Performance standards for antimicrobial susceptibility testing: 11th informational supplement. Vol. 21, M100-S11. National Committee for Clinical Laboratory Standards, Wayne, PA). The MIC was defined as the lowest concentration of each compound resulting in inhibition of visible growth of bacteria after incubation at 37 °C for 18-24 h.